Search Results for: MLNT

Tuesday’s Biggest Biotech Movers

Tuesday was a breakout day for a few biotech companies that saw solid gains. With the markets at all-time highs, these companies could help push things higher. 24/7 Wall St. ...
Read Full Story »

Why This FDA Approval for Pneumonia Treatment Is So Huge

This story has been updated for share price impact. Melinta Therapeutics, Inc. (NASDAQ: MLNT) shares nearly doubled early on Wednesday after the firm announced that the U.S. Food and Drug ...
Read Full Story »

Melinta Therapeutics Loses Again Despite Positive Phase 3 Results

Melinta Therapeutics Inc. (NASDAQ: MLNT) shares dropped on Monday despite the company announcing positive top-line results from its Phase 3 trial of Baxdela (delafloxacin) for the treatment of adult patients ...
Read Full Story »

5 More Stocks to Buy Trading Under $10 With Huge Upside Potential

While Most of Wall Street focuses on large and mega-cap stocks, as they provide a degree of safety and liquidity, many investors are limited in the number of shares they ...
Read Full Story »

Jefferies Biotech Growth Picks Have Big Upside Potential

Increasingly, the companies on Wall Street that we cover are starting to agree that while the future's still bright for the U.S. economy, the future may be one of stock market ...
Read Full Story »

Why Melinta Therapeutics Shares Are Getting Crushed

Melinta Therapeutics Inc. (NASDAQ: MLNT) saw its shares plunge on Thursday after the firm announced that it had priced its secondary offering. Essentially, the firm is looking to raise more ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Amazon, Barrick Gold, Boston Scientific, Chipotle, Gap, Gilead, Goldcorp, Workday and More

Stocks set yet another record on the Dow and S&P, but some top chip and tech names have started finding some cracks after massive gains in 2017. The major indexes ...
Read Full Story »